Advice You
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > EU Protects Own Shoe Industry Against Asian Exporters

Tags

  • likely
  • exports
  • through
  • childrens footwear
  • childrens footwear
  • companies involved

  • Links

  • Sample; Territory Reduction Policy for a Franchise Company
  • Travel Insurance Can Make A World Of Difference To Your Holiday
  • Say No To Spam In Your Inbox!
  • Advice You - EU Protects Own Shoe Industry Against Asian Exporters

    In a bid to protect its own shoe-making and leather industries, the European Union proposed anti-dumping policies and duties against Asian shoes. The EU stated its
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    intent last Tuesday as Asian exporters like India, Vietnam, and China flood European markets with cheaper but quality shoes. The EU felt that the low cost of Asia
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    n shoe exports threaten fair trade in the markets of Europe. If the EU succeeds in its bid, Asian exporters are likely to face an increase on tariff and exportatio
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    n fees.

    It was reported that the governments of EU-member countries would conduct a month-long debate about the proposed extra charge on Asian exporters. If appro
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ved, these extra charges may amount to an increase of 16.5% on Chinese shoes and ten percent for Vietnamese exports. The proposed increase is projected to affect 1
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    1 percent of every footwear pair purchased in EU's markets. The proposed increase will affect every kind of footwear exports from children's footwear to custom-des
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    igned shoes. The EU, in its proposal, pegged the duration of the tariff amendment for five years.

    The EU officials stated that the extra duties and dues could inc
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rease the average cost of Chinese and other Asian shoes by euro1.40 or roughly almost two dollars in retail. If the Asian exporters and their EU partners decided t
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    o let the public shoulder the added costs, Asian shoe prices may cost euro36.4 or $46. The Asian shoe industry, particularly those of China, India, and Vietnam, ar
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    e likely to suffer much as their main market -- children's footwear -- are absorbed into the policy.

    The EU, for its part, defended its call to absorb kiddie shoe
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    s in the program. According to EU officials, the Asian shoe exporters and importers trick the system and the customs by labeling the smaller sizes of ladies' footw
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ear as kiddie shoes. This had damaged the EU shoe manufacturing industry greatly according to reports. The reports and profit statistics indicated that European sh
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    oe production decreased by as much as 30% since the late 2001. Coincidentally, this is also the period when Asian shoes experience an upsurge in sales due to low i
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    mportation and exportation costs. Because of the low costs in production and tariff fees, Asian shoe manufacturers were able to sell and dump the shoes in the mark
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ets of Europe for cheap prices against which the EU shoe industry cannot compete.

    In EU, there is an estimate of 40,000 lost jobs presently. Although not solely b
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ecause of the Asian exporters, they stiff competition posed by the Asian manufacturers aggravate the situation. The governments behind EU are split in supporting t
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    he proposal. If the situations do not change, the Asian shoe industry may still enjoy lower transport cost come October. The EU needs to be unified to implement th
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    e proposed increase in October.

    Meanwhile, calls from the Asian community and shoe exporters are faced with deaf ears of the EU. The EU labeled the Asian shoe imp
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    orters and exporters as cheaters. The shoe industry of Vietnam and China did not take the insult sitting down and denied the allegations. They, in turn, accused th
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e EU governments of protectionism. Whatever the outcome of this shoe deal is, it is clear that the economy of EU and the Asian industries will be severely affected


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.adviceyou.org.ua/article/2591/adviceyou-EU-Protects-Own-Shoe-Industry-Against-Asian-Exporters.html">EU Protects Own Shoe Industry Against Asian Exporters</a>

    BB link (for phorums):
    [url=http://www.adviceyou.org.ua/article/2591/adviceyou-EU-Protects-Own-Shoe-Industry-Against-Asian-Exporters.html]EU Protects Own Shoe Industry Against Asian Exporters[/url]

    Related Articles:

    Ideal or Real Food Cost in the Restaurant Business

    How To Gear Up Your Network

    How Can I Make Money With Surveys On The Web

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    porównywarka cen gov.darkseo.pl/podmiot-gdansku.html Sylwester Portugalia Oferty sylwestrowe stomatolog wrocław